Expression of human α1-proteinase inhibitor in Aspergillus niger
2007

Producing Human α1-Proteinase Inhibitor in Fungi

publication 10 minutes Evidence: moderate

Author Information

Author(s): Elena Karnaukhova, Ophir Yakir, Trinh Loc, Dalal Nimish, Punt Peter J, Golding Basil, Shiloach Joseph

Primary Institution: Center for Biologics Evaluation and Research, Food and Drug Administration

Hypothesis

Can the human gene for α1-proteinase inhibitor be expressed in Aspergillus niger to produce a stable and active protein?

Conclusion

The study successfully expressed the human α1-proteinase inhibitor in Aspergillus niger, yielding a biologically active glycosylated protein with improved stability.

Supporting Evidence

  • The yields of recombinant α1-PI reached up to 12 mg/L in shake-flask cultures.
  • The molecular mass of the recombinant protein was similar to that of the plasma-derived version.
  • The recombinant protein showed improved stability compared to non-glycosylated versions from E. coli.
  • The study utilized various assays including SDS-PAGE, Western blot, and ELISA to confirm protein activity.

Takeaway

Scientists figured out how to make a special protein that helps people breathe better using a type of fungus, which is better than making it from blood.

Methodology

The human α1-PI gene was expressed in Aspergillus niger using a fusion protein strategy, and various assays were conducted to evaluate protein activity and stability.

Limitations

The study did not explore the full range of potential proteolytic processing variations in the expressed protein.

Digital Object Identifier (DOI)

10.1186/1475-2859-6-34

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication